Cargando…

Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment

Plasma-based biomarkers present a promising approach in the research and clinical practice of Alzheimer's disease as they are inexpensive, accessible and minimally invasive. In particular, prognostic biomarkers of cognitive decline may aid in planning and management of clinical care. Although r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kivisäkk, Pia, Magdamo, Colin, Trombetta, Bianca A, Noori, Ayush, Kuo, Yi kai E, Chibnik, Lori B, Carlyle, Becky C, Serrano-Pozo, Alberto, Scherzer, Clemens R, Hyman, Bradley T, Das, Sudeshna, Arnold, Steven E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257670/ https://www.ncbi.nlm.nih.gov/pubmed/35800899 http://dx.doi.org/10.1093/braincomms/fcac155

Ejemplares similares

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023)

Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease
por: Carlyle, Becky C., et al.
Publicado: (2022)

Cyclic multiplex fluorescent immunohistochemistry and machine learning reveal distinct states of astrocytes and microglia in normal aging and Alzheimer’s disease
por: Muñoz-Castro, Clara, et al.
Publicado: (2022)

Meta-analysis of mouse transcriptomic studies supports a context-dependent astrocyte reaction in acute CNS injury versus neurodegeneration
por: Das, Sudeshna, et al.
Publicado: (2020)

Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease
por: Qian, Jing, et al.
Publicado: (2021)

Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration
por: Noori, Ayush, et al.
Publicado: (2020)

Differential gene expression data from the human central nervous system across Alzheimer's disease, Lewy body diseases, and the amyotrophic lateral sclerosis and frontotemporal dementia spectrum
por: Noori, Ayush, et al.
Publicado: (2021)

Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics
por: Carlyle, Becky C., et al.
Publicado: (2021)

Systematic review of human post‐mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease
por: Viejo, Lucía, et al.
Publicado: (2021)

Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias
por: Carlyle, Becky C., et al.
Publicado: (2018)

Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline
por: Ismail, Zahinoor, et al.
Publicado: (2021)

Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
por: Kivisäkk, Pia, et al.
Publicado: (2022)

Cerebrospinal Fluid and Brain Proteoforms of the Granin Neuropeptide Family in Alzheimer’s Disease
por: Quinn, James P., et al.
Publicado: (2023)

Correction to “Cerebrospinal Fluid and Brain Proteoforms of the Granin Neuropeptide Family in Alzheimer’s Disease”
por: Quinn, James P., et al.
Publicado: (2023)

Development and Evaluation of a Natural Language Processing Annotation Tool to Facilitate Phenotyping of Cognitive Status in Electronic Health Records: Diagnostic Study
por: Noori, Ayush, et al.
Publicado: (2022)

Neuropathology-Independent Association Between APOE Genotype and Cognitive Decline Rate in the Normal Aging-Early Alzheimer Continuum
por: Qian, Jing, et al.
Publicado: (2023)

Microstructural brain changes track cognitive decline in mild cognitive impairment
por: Reas, Emilie T., et al.
Publicado: (2018)

The effect of statins on rate of cognitive decline in mild cognitive impairment
por: Smith, Kyle B., et al.
Publicado: (2017)

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
por: Eliassen, Carl F., et al.
Publicado: (2017)

Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment
por: Cloutier, Simon, et al.
Publicado: (2015)

Trajectories of subjective cognitive decline, and the risk of mild cognitive impairment and dementia
por: Liew, Tau Ming
Publicado: (2020)

Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment
por: Roberto, Natalia, et al.
Publicado: (2021)

Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment
por: Bainbridge, Wilma A., et al.
Publicado: (2019)

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
por: Xiong, Lisa Y., et al.
Publicado: (2021)

VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases
por: Quinn, James P, et al.
Publicado: (2021)

Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
por: Kim, Sangsoon, et al.
Publicado: (2016)

Oxidative stress and aberrant signaling in aging and cognitive decline
por: Dröge, Wulf, et al.
Publicado: (2007)

From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution
por: Cheng, Yu-Wen, et al.
Publicado: (2017)

Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia
por: Liew, Tau Ming
Publicado: (2020)

Psychological stress, cognitive decline and the development of dementia in amnestic mild cognitive impairment
por: Sussams, Rebecca, et al.
Publicado: (2020)

Capturing Subjective Mild Cognitive Decline in Parkinson’s Disease
por: Rosenblum, Sara, et al.
Publicado: (2022)

IGF2R circular RNA hsa_circ_0131235 expression in the middle temporal cortex is associated with AD pathology
por: Bigarré, Inès M., et al.
Publicado: (2021)

COPING WITH COGNITIVE DECLINE AMONG OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT OR MILD DEMENTIA: A SCOPING REVIEW
por: Cho, Youngmin, et al.
Publicado: (2022)

Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer’s disease
por: Sohn, Dongwha, et al.
Publicado: (2018)

Association of Posttraumatic Stress Disorder With Accelerated Cognitive Decline in Middle-aged Women
por: Roberts, Andrea L., et al.
Publicado: (2022)

Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis
por: Pieper, Nina T, et al.
Publicado: (2020)

White matter hyperintensities, incident mild cognitive impairment, and cognitive decline in old age
por: Boyle, Patricia A., et al.
Publicado: (2016)

Blood Pressure in Different Dementia Disorders, Mild Cognitive Impairment, and Subjective Cognitive Decline
por: Hestad, Knut, et al.
Publicado: (2020)

Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer’s Disease
por: Guan, Jingjing, et al.
Publicado: (2020)

Prediction of 7‐year's conversion from subjective cognitive decline to mild cognitive impairment
por: Yue, Ling, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0tsrris6e83l5qgt87j2293s6e